Which of the following statements regarding Hashimoto's thyroiditis is FALSE?
Pheochromocytoma is usually associated with?
A 37-year-old woman presents with a one-week history of difficulty swallowing and a feeling of fullness in the anterior neck. She had a mild upper respiratory tract infection one month prior. On examination, her temperature is 37.4°C, pulse is 74/min, respirations are 16/min, and blood pressure is 122/80 mm Hg. Palpation of her diffusely enlarged thyroid is painful. Laboratory studies reveal an increased serum T4 level and a decreased TSH level. Two months later, her symptoms have resolved, and her T4 level is normal. Which of the following conditions is most likely to have produced these findings?
FNAC is the least diagnostic in which of the following thyroid conditions?
Calcitonin is a marker of which thyroid malignancy?
For which one of the following tumors is gastrin a biochemical marker?
A 36-year-old woman presents with a nontender thyroid nodule, intermittent watery diarrhea, and a family history of thyroid cancer. A needle biopsy reveals malignant cells and homogeneous eosinophilic material. The thyroid nodule is found to be "cold" by radioiodine scintiscan. Congo red staining of the nodule reveals birefringent amyloid stroma, and genetic studies show a familial cancer syndrome. In addition to hyperparathyroidism, which of the following neoplastic diseases is this patient at risk of developing?
The term fetal adenoma is used for which of the following conditions?
Anti-thyroglobulin antibodies are seen in which of the following conditions?
What is the only reliable method to distinguish between a follicular adenoma and a follicular carcinoma?
Explanation: **Explanation** Hashimoto’s Thyroiditis (Chronic Lymphocytic Thyroiditis) is the most common cause of hypothyroidism in iodine-sufficient regions. It is an autoimmune destruction of the thyroid gland mediated by T-cell-induced apoptosis and autoantibodies (Anti-TPO and Anti-Tg) [2]. **Why Option D is Correct:** All the provided statements (A, B, and C) are factually incorrect based on clinical and pathological evidence: * **Statement A is False:** While the hallmark of Hashimoto’s is a **lymphocytic and plasma cell infiltrate** with germinal centers [1], **neutrophils** can be seen, particularly in the early "Hashitoxicosis" phase or when there is concurrent focal necrosis [1]. * **Statement B is False:** Although the peak incidence is in women aged **45–65 years**, Hashimoto’s is the **most common cause of sporadic goiter in children** and adolescents. It is not exclusive to middle age. * **Statement C is False:** Hashimoto’s is typically a "painless goiter." However, a subset of patients (Painful Hashimoto’s Thyroiditis) presents with significant **thyroid pain and tenderness**, which can radiate to the hyoid or jaw region, mimicking De Quervain’s thyroiditis. **High-Yield Clinical Pearls for NEET-PG:** * **Histology:** Look for **Hürthle cells** (Askanazy cells)—follicular epithelial cells with abundant, granular, eosinophilic cytoplasm due to mitochondrial stress [1]. * **Genetics:** Strongly associated with **HLA-DR3** and **HLA-DR5**. * **Risk of Malignancy:** Patients have an increased risk of developing **B-cell Non-Hodgkin Lymphoma** (specifically MALT lymphoma) and potentially Papillary Thyroid Carcinoma [3]. * **Serology:** High titers of **Anti-Thyroid Peroxidase (Anti-TPO)** and **Anti-Thyroglobulin (Anti-Tg)** antibodies. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1090-1091. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1089-1090. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 235-236.
Explanation: **Explanation:** **Pheochromocytoma** is a catecholamine-secreting tumor derived from the chromaffin cells of the adrenal medulla [1]. While most cases are sporadic, approximately 25–30% are associated with hereditary syndromes [1]. **Why Neurofibromatosis is Correct:** **Neurofibromatosis Type 1 (NF1)**, caused by a mutation in the *NF1* gene on chromosome 17, is a well-established neurocutaneous syndrome associated with pheochromocytoma [1]. Although it occurs in only about 1–5% of NF1 patients, the association is a classic medical fact [1]. Other major associations include **MEN 2A and 2B** (*RET* proto-oncogene) and **Von Hippel-Lindau (VHL) disease** [1]. **Analysis of Incorrect Options:** * **Pancreatic exocrine carcinoma:** There is no known genetic or clinical link between pheochromocytoma and exocrine pancreatic cancer. However, pheochromocytoma *is* associated with pancreatic **neuroendocrine** tumors (Islet cell tumors) in MEN 1 (rarely) or VHL [1]. * **Astrocytoma:** While NF1 patients are prone to gliomas (specifically optic nerve gliomas), astrocytomas are not the primary tumor associated with pheochromocytoma [1]. * **Neuroblastoma:** This is a common childhood tumor also derived from neural crest cells, but it is a separate clinical entity and does not typically co-occur with pheochromocytoma as part of a syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of 10s:** 10% bilateral, 10% malignant, 10% extra-adrenal (Paraganglioma), 10% pediatric, and 10% calcify (though recent data suggests familial cases are now closer to 30%). * **Diagnosis:** Best initial screening test is **Urinary/Plasma Metanephrines**. * **Zellballen Pattern:** Histology shows nests of cells surrounded by sustentacular cells. * **Classic Triad:** Episodic headache, sweating (diaphoresis), and tachycardia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1137.
Explanation: The clinical presentation of a **painful, tender thyroid** following a **viral upper respiratory tract infection (URTI)** is the classic hallmark of **Subacute Granulomatous Thyroiditis (de Quervain thyroiditis)** [1]. **1. Why the Correct Answer is Right:** Subacute granulomatous thyroiditis is a self-limiting inflammatory condition, likely post-viral in etiology. The pathology involves the destruction of thyroid follicles, leading to the leakage of preformed thyroid hormones into the blood [1]. This causes a transient **hyperthyroid phase** (high T4, low TSH), followed by a brief hypothyroid phase, and eventually a return to **euthyroid state** within 2–4 months [1]. The hallmark is a **tender, enlarged gland** and an elevated Erythrocyte Sedimentation Rate (ESR) [1]. **2. Why Incorrect Options are Wrong:** * **Hashimoto Thyroiditis:** While it causes diffuse enlargement, it is typically **painless**. It is an autoimmune destruction leading to permanent hypothyroidism, not a transient resolution. * **Medullary Thyroid Carcinoma:** This is a neoplasm of parafollicular C-cells. It presents as a **painless, firm nodule** and does not cause transient thyrotoxicosis or follow a viral prodrome. * **Toxic Follicular Adenoma:** This is a "hot" nodule that autonomously produces thyroid hormone [1]. It presents as a **painless** solitary nodule and does not resolve spontaneously; it causes persistent hyperthyroidism. **3. NEET-PG High-Yield Pearls:** * **Most common cause of thyroid pain:** Subacute Granulomatous Thyroiditis [1]. * **Microscopy:** Characterized by **multinucleated giant cells** and granulomatous inflammation surrounding collapsed follicles. * **Diagnostic Clue:** Low radioactive iodine uptake (RAIU) during the thyrotoxic phase (due to follicular damage, not hyperfunctioning tissue) [1]. * **HLA Association:** Strongly associated with **HLA-B35**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1087, 1091-1092.
Explanation: **Explanation:** The correct answer is **Follicular Carcinoma**. **1. Why Follicular Carcinoma is the correct answer:** Fine Needle Aspiration Cytology (FNAC) evaluates individual cells or small clusters (cytology), but it cannot assess tissue architecture. The definitive diagnosis of Follicular Carcinoma requires the identification of **capsular invasion** or **vascular invasion** [1]. Since FNAC only samples cells from within the nodule, it cannot visualize the integrity of the capsule or the surrounding blood vessels [1]. Therefore, FNAC can identify a "Follicular Neoplasm" but cannot distinguish between a benign Follicular Adenoma and a malignant Follicular Carcinoma. Histopathology (biopsy) is mandatory for diagnosis. **2. Why other options are incorrect:** * **Anaplastic Carcinoma:** FNAC is highly diagnostic as it shows overt features of malignancy, such as extreme pleomorphism, giant cells, and spindle cells [4]. * **Papillary Carcinoma:** This is the most common thyroid cancer and is easily diagnosed via FNAC based on characteristic nuclear features: **Orphan Annie eye nuclei** (clearing), **nuclear grooves**, and **pseudo-inclusions** [2], [3]. * **Thyroiditis:** Conditions like Hashimoto’s thyroiditis show distinct cytological patterns, including Hurthle cells and a dense lymphocytic background, making FNAC very useful. **Clinical Pearls for NEET-PG:** * **Gold Standard for Thyroid Nodules:** FNAC is the initial investigation of choice for any thyroid nodule. * **Psammoma Bodies:** Frequently seen in Papillary Carcinoma (laminated calcifications). * **Amyloid Stroma:** Characteristic of Medullary Carcinoma (diagnosed via FNAC + Calcitonin staining). * **Hurthle Cells:** Found in both Hashimoto’s thyroiditis and Hurthle cell tumors (a variant of follicular neoplasm). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1100-1101. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1099. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 429-430. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1101-1102.
Explanation: **Medullary Thyroid Carcinoma (MTC)** is a neuroendocrine tumor derived from the **Parafollicular C-cells** of the thyroid gland [1], [2]. These cells are embryologically derived from the neural crest and are responsible for the secretion of **Calcitonin**, a hormone involved in calcium homeostasis [2]. Therefore, serum calcitonin serves as a highly specific tumor marker for the diagnosis, screening, and monitoring of recurrence in MTC [1]. **Analysis of Options:** * **Papillary Carcinoma (Option A):** This is the most common thyroid malignancy. It arises from follicular epithelium and typically secretes **Thyroglobulin**, not calcitonin. It is characterized by "Orphan Annie eye" nuclei and Psammoma bodies. * **Anaplastic Carcinoma (Option C):** An undifferentiated, highly aggressive tumor of the follicular epithelium [2]. It lacks the functional capacity to produce specific hormones like calcitonin and usually presents in elderly patients with a rapidly enlarging neck mass. * **Adenocarcinoma (Option D):** This is a general term for glandular cancers. While most thyroid cancers are technically adenocarcinomas, the term is non-specific and does not define the calcitonin-secreting properties unique to MTC. **High-Yield Clinical Pearls for NEET-PG:** * **Amyloid Stroma:** Histologically, MTC shows nests of cells in a prominent amyloid stroma (formed by altered calcitonin propeptides), which stains with **Congo Red** [2]. * **Genetics:** Approximately 25% of cases are familial, associated with **MEN 2A and 2B** syndromes [1], [2]. These are linked to germline mutations in the **RET proto-oncogene**. * **CEA:** Carcinoembryonic antigen (CEA) is also often elevated in MTC and is used alongside calcitonin for follow-up [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1103. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 424-431.
Explanation: **Explanation:** The correct answer is **Pancreatic neuroendocrine tumor (PanNET)**. Gastrin is a peptide hormone primarily produced by G-cells in the gastric antrum and duodenum. However, it serves as a specific biochemical marker for **Gastrinomas**, which are a subtype of functional pancreatic neuroendocrine tumors [1]. These tumors lead to **Zollinger-Ellison Syndrome (ZES)**, characterized by hypergastrinemia, gastric acid hypersecretion, and refractory peptic ulcers [1]. While most gastrinomas occur in the "Gastrinoma Triangle" (duodenum and pancreas), they are classically categorized under PanNETs in the context of biochemical markers [1]. **Analysis of Incorrect Options:** * **Medullary Carcinoma of Thyroid (MTC):** The hallmark biochemical marker is **Calcitonin**. Carceaembryonic antigen (CEA) is also used for monitoring. * **Pheochromocytoma:** This tumor of the adrenal medulla produces catecholamines [2]. The diagnostic markers are urinary and plasma **Metanephrines** and Vanillylmandellic acid (VMA). * **Gastrointestinal Stromal Tumor (GIST):** These are mesenchymal tumors, not endocrine. The key diagnostic marker is the immunohistochemical expression of **CD117 (c-KIT)** or **DOG1**, rather than a secreted hormone. **High-Yield Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle:** Boundaries are the junction of the cystic/common bile duct, the junction of the 2nd and 3rd parts of the duodenum, and the neck/body of the pancreas [1]. * **MEN1 Syndrome:** Gastrinomas are the most common functional PanNET associated with Multiple Endocrine Neoplasia Type 1 (The 3 P’s: Pituitary, Parathyroid, Pancreas) [1]. * **Chromogranin A:** This is a non-specific but universal serum marker for almost all neuroendocrine tumors, including PanNETs and Pheochromocytomas. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1124-1125. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1138-1139.
Explanation: **Explanation:** The clinical presentation points toward **Medullary Thyroid Carcinoma (MTC)**. The key diagnostic features include a "cold" thyroid nodule, watery diarrhea (due to secretion of VIP or prostaglandins) [2], and characteristic histopathology showing malignant cells with **amyloid stroma** (derived from procalcitonin) that exhibits apple-green birefringence under Congo red staining [1]. The mention of a family history and a "familial cancer syndrome" indicates **Multiple Endocrine Neoplasia (MEN) type 2**. MTC is a component of both MEN 2A and 2B [1]. Given the patient also has **hyperparathyroidism**, the diagnosis is specifically **MEN 2A (Sipple Syndrome)** [2]. **MEN 2A consists of the "3 Ps":** 1. **M**edullary Thyroid Carcinoma 2. **P**heochromocytoma (Option D) [2] 3. **P**arathyroid Hyperplasia [2] **Why other options are incorrect:** * **A. Craniopharyngioma:** A suprasellar tumor derived from Rathke’s pouch; not associated with MEN syndromes. * **B. Follicular adenoma:** A benign tumor of thyroid follicular cells. MTC arises from parafollicular C-cells [1]. * **C. Neuroblastoma:** A common pediatric adrenal tumor; not part of the MEN 2A constellation. **NEET-PG High-Yield Pearls:** * **Genetic Mutation:** MEN 2A and 2B are associated with germline mutations in the **RET proto-oncogene** (receptor tyrosine kinase) [2]. * **MEN 2B:** Includes MTC and Pheochromocytoma (like 2A) but features **Mucosal Neuromas** and **Marfanoid habitus** instead of hyperparathyroidism [2]. * **Tumor Marker:** Serum **Calcitonin** is used for diagnosis and monitoring recurrence of MTC [2]. * **Management:** Prophylactic thyroidectomy is often recommended for RET mutation carriers. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1102-1137.
Explanation: The term **fetal adenoma** refers to a specific histological subtype of **follicular adenoma of the thyroid**. It is characterized by the presence of small, closely packed follicles containing little or no colloid, resembling the primitive thyroid tissue seen in a fetus [2]. **Why the correct answer is right:** Follicular adenomas are benign encapsulated tumors of the thyroid [1]. Based on the growth pattern and size of the follicles, they are classified into several types: * **Fetal (Microfollicular):** Small follicles with scant colloid [2]. * **Embryonal (Trabecular):** Solid cords of cells with no follicle formation. * **Colloid (Macrofollicular):** Large follicles distended with colloid. * **Hürthle cell (Oxyphilic):** Composed of eosinophilic, granular cells [1]. **Why other options are incorrect:** * **Hepatoma (Hepatocellular Carcinoma):** This is a primary malignancy of the liver. While "Hepatoblastoma" occurs in children, the term fetal adenoma is not used here. * **Fibroadenoma of the breast:** This is a biphasic tumor (epithelial and stromal). While common in young women, it is not termed "fetal." * **Craniopharyngioma:** These are tumors derived from Rathke’s pouch. While they can have an "adamantinomatous" pattern (resembling tooth-forming organs), they are not called fetal adenomas. **High-Yield Pearls for NEET-PG:** 1. **Hallmark of Follicular Adenoma:** A complete, intact fibrous capsule [1]. If there is **capsular or vascular invasion**, the diagnosis changes to **Follicular Carcinoma**. 2. **Fine Needle Aspiration (FNA):** Cannot distinguish between follicular adenoma and carcinoma; histopathology of the entire capsule is required [1]. 3. **Cold Nodule:** Most follicular adenomas appear as "cold" (non-functional) nodules on radioactive iodine uptake scans. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1096-1097. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429.
Explanation: **Explanation:** **Hashimoto Thyroiditis (Chronic Lymphocytic Thyroiditis)** is an autoimmune disorder characterized by the destruction of thyroid follicles by T-cell mediated cytotoxicity and autoantibody production [1]. The hallmark of this condition is the presence of high titers of circulating antithyroid antibodies, specifically **Anti-thyroglobulin (Anti-Tg)** and **Anti-thyroid peroxidase (Anti-TPO)** antibodies. Anti-TPO is more sensitive (present in >90% of cases), but Anti-Tg is a classic marker used for diagnosis. **Analysis of Incorrect Options:** * **Graves Disease:** While Anti-TPO and Anti-Tg can be present, the diagnostic hallmark is **Thyroid Stimulating Immunoglobulin (TSI)** or TSH-receptor antibodies, which cause hyperthyroidism [3]. * **De Quervain Thyroiditis (Subacute Granulomatous):** This is a post-viral inflammatory condition, not an autoimmune one. It is characterized by a high ESR and painful thyroid, but autoantibodies are typically absent or transiently low. * **Subacute Lymphocytic Thyroiditis (Painless Thyroiditis):** Although this is considered a variant of Hashimoto’s and can show Anti-TPO antibodies, Hashimoto thyroiditis remains the primary and most definitive association for high-titer Anti-Tg in exam contexts. **NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Fine Needle Aspiration Cytology (FNAC) showing **Hurthle cells** (Askanazy cells) and dense lymphocytic infiltrates with germinal centers. * **HLA Association:** Strongly linked with **HLA-DR3** and **HLA-DR5**. * **Risk of Malignancy:** Patients have an increased risk of developing **B-cell Non-Hodgkin Lymphoma** (specifically MALT lymphoma) and Papillary Thyroid Carcinoma [2]. * **Clinical Course:** Often presents with a transient "Hashitoxicosis" followed by permanent hypothyroidism. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1089-1090. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 235-236. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 213-214.
Explanation: **Explanation:** The distinction between **Follicular Adenoma** and **Follicular Carcinoma** is a classic high-yield topic in endocrine pathology. Both tumors are composed of follicles and can appear identical on Fine Needle Aspiration Cytology (FNAC) [1]. **Why Option A is Correct:** The diagnosis of Follicular Carcinoma is strictly based on histological evidence of **capsular invasion** (full-thickness penetration of the tumor capsule) or **vascular/angioinvasion** (tumor cells within a vessel in or outside the capsule) [1], [3]. Since these features can only be identified by examining the entire capsule under a microscope, a definitive diagnosis requires surgical excision (lobectomy or thyroidectomy) and histopathology [1]. **Why Other Options are Incorrect:** * **Radiography (Option B):** Imaging (Ultrasound/CT) can identify nodules and suspicious features like microcalcifications, but it cannot visualize microscopic capsular or vascular breaches. * **Peripheral Smear (Option C):** Thyroid cancers do not typically shed cells into the systemic circulation in a manner detectable by a routine peripheral blood smear. **NEET-PG High-Yield Pearls:** * **FNAC Limitation:** FNAC can identify a "follicular neoplasm" but **cannot** distinguish between adenoma and carcinoma because it only samples cells, not the capsule [1]. * **Spread:** Unlike Papillary Carcinoma (which spreads via lymphatics), Follicular Carcinoma spreads primarily via the **hematogenous route** to bones and lungs [3]. * **Molecular Marker:** *PAX8-PPARG* fusion and *RAS* mutations are commonly associated with follicular neoplasms [2]. * **Hürthle Cell Carcinoma:** A variant of follicular carcinoma characterized by eosinophilic, granular cytoplasm (oncocytes) due to abundant mitochondria [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1096-1101. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1099-1100. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 428-429.
Pituitary Gland Disorders
Practice Questions
Thyroid Gland Diseases
Practice Questions
Parathyroid Gland Pathology
Practice Questions
Adrenal Cortical Disorders
Practice Questions
Adrenal Medullary Disorders
Practice Questions
Pancreatic Endocrine Disorders
Practice Questions
Multiple Endocrine Neoplasia Syndromes
Practice Questions
Diffuse Neuroendocrine System
Practice Questions
Pineal Gland Pathology
Practice Questions
Laboratory Diagnosis of Endocrine Diseases
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free